reboxetine has been researched along with haloperidol in 4 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 20,330 | 1,753 | 3,294 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berk, M; Schutz, G | 1 |
| Abumaria, N; Flügge, G; Fuchs, E; Havemann-Reinecke, U; Hiemke, C; Rüther, E; Rygula, R; Zernig, G | 1 |
| Artigas, F; Bortolozzi, A; Masana, M | 1 |
| Bastlund, JF; Bundgaard, C; Glenthøj, BY; Mørk, A; Oranje, B; Steiniger-Brach, B; Witten, L | 1 |
1 trial(s) available for reboxetine and haloperidol
| Article | Year |
|---|---|
Reboxetine add on therapy to haloperidol in the treatment of schizophrenia: a preliminary double-blind randomized placebo-controlled study.
Topics: Adult; Antidepressive Agents; Chronic Disease; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2001 |
3 other study(ies) available for reboxetine and haloperidol
| Article | Year |
|---|---|
Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Male; Morpholines; Motivation; Motor Activity; Rats; Rats, Wistar; Reboxetine; Reward; Stress, Psychological | 2008 |
Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
Topics: Adrenergic Agents; Animals; Antipsychotic Agents; Cognition; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Electric Stimulation; Haloperidol; Idazoxan; Male; Microdialysis; Molecular Targeted Therapy; Morpholines; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Reboxetine; Schizophrenia; Synaptic Transmission; Ventral Tegmental Area | 2011 |
Comparing Pharmacological Modulation of Sensory Gating in Healthy Humans and Rats: The Effects of Reboxetine and Haloperidol.
Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Adult; Animals; Auditory Perception; CA3 Region, Hippocampal; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Evoked Potentials, Auditory; Haloperidol; Humans; Male; Morpholines; Rats; Reboxetine; Sensory Gating; Species Specificity; Young Adult | 2016 |